Pre-Annual General Meeting Information • Apr 8, 2024
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer

Notice of Annual General Meeting to be held on Wednesday, 8 May 2024

If you are in any doubt as to any aspect of the proposals referred to in this document or as to the action you should take, you should seek your own advice from a stockbroker, solicitor, accountant, or other professional adviser.
If you have sold or transferred all of your shares in Direct Line Insurance Group plc (the "Company"), you should pass this Notice of Annual General Meeting (the "Notice") and accompanying documents (except any personalised form of proxy) to the purchaser or transferee, or to the person who arranged the sale or transfer so they can pass these documents to the person who now holds the shares.
| Letter from the Chair | 3 |
|---|---|
| AGM Information | 4 |
| Notice of Annual General Meeting | 5 |
| General Notes | 8 |
| The Business of the Annual General Meeting | 10 |
| Shareholder Information | 20 |
| Statement of Circumstances | 21 |
Dear Shareholder,
I am pleased to enclose the Notice of Meeting for the Company's 2024 AGM (the "Notice"). The AGM will be held at the offices of the Company at Riverbank House, 2 Swan Lane, London, EC4R 3AD, on Wednesday, 8 May 2024 at 10.30 a.m.
The Notice sets out the resolutions to be proposed, together with explanatory notes and general notes for shareholders who wish to give proxy voting instructions electronically or by post. The Company's Annual Report & Accounts 2023 are available to view on the Investor section of our website: www. directlinegroup.co.uk/en/investors/.
All of the current Directors are standing for re-election at this year's AGM, except for Adam Winslow, David Neave and Carol Hagh, who are standing for election by shareholders for the first time. Biographical details of all the Directors standing for election or re-election are provided in the explanatory notes to the relevant resolutions, and in the Annual Report & Accounts. The Board has assessed the performance and time commitments of all the Directors and recommends that shareholders vote in favour of those resolutions.
Jon Greenwood, who was our Acting CEO, stood down from the Board on 21 March 2024. I would like to thank Jon for his outstanding stewardship of the Company for the past year.
You will see in resolution 3 in the Notice that the Board is recommending a final dividend for the year ended 31 December 2023 of 4.0 pence per share, which, subject to approval by shareholders, will become due and payable on 17 May 2024 to shareholders named on the Register of Members at the close of business on 5 April 2024, provided that the Board may cancel the dividend and therefore payment of the dividend at any time prior to payment, if it considers it necessary to do so for regulatory capital purposes.
Following a competitive tender process in 2022, details of which are set out on page 119 of the Annual Report and Accounts 2022, it is proposed to appoint KPMG LLP as the Company's new external auditor for the financial year ending 31 December 2024, subject to shareholder approval at the AGM. I would like to extend my appreciation to Deloitte LLP for their services as auditor and draw your attention to their statement of circumstances on page 21.
Shareholders will recall that for the last seven years we have requested shareholder approval for the Company to issue restricted Tier 1 capital instruments compliant with the prudential regime applicable to the Company ("RT1 Instruments"). In December 2017 the Directors used the authority granted at the 2017 AGM for the issue of RT1 Instruments with a nominal value of £350 million. Since 2017, the Directors have not used the authority granted at subsequent AGMs held to date.
The 2023 authority expires at the end of this AGM and we are seeking revised authorities (in resolutions 24 and 25) to allow the Company to have continued flexibility to issue further RT1 Instruments to manage and maintain its and the Group's capital more effectively. Capital sourced in this way contributes towards the Group's prudential capital requirements.
A key feature of RT1 Instruments is that they would automatically convert into shares (1) if at any time the amount of relevant Own Funds items were to fall below the level necessary to exceed (a) any relevant Minimum Capital Requirement or (b) 75% of any relevant Solvency Capital Requirement or (2) if we were to breach any relevant Solvency Capital Requirement and fail to remedy that breach within three months. If one of those triggers were to occur, the £350 million RT1 Instruments we issued in December 2017 would convert into approximately 137 million shares (based on the current conversion price).
Shareholders may send any questions about the business of the AGM to the Company Secretary by email at [email protected]. We will provide written answers to questions registered in this way. Shareholders attending the meeting on the day may ask questions during the meeting in the usual way.
Your vote is important to us. Whether or not you intend to join us for the AGM, you can vote by submitting your proxy instruction online or by signing and returning your proxy form which should be submitted by no later than 10.30 a.m. on Friday, 3 May 2023. Voting instructions are set out in the notes on pages 8,9 and 20. The voting results will be announced to the London Stock Exchange and published on our website at www.directlinegroup.co.uk/en/investors/regulatory-news following the conclusion of the meeting.
Your Board of Directors believes the resolutions to be proposed at the AGM will promote the success of the Company and are in the best interests of the Company and its shareholders as a whole. The Directors unanimously recommend you vote in favour of them, as they intend to do in respect of their own beneficial shareholdings.

Danuta Gray Chair
The offices of the Company at Riverbank House, 2 Swan Lane, London, EC4R 3AD
The meeting will start at 10.30 a.m. Please arrive no later than 10.15 a.m. for registration.
Tea and coffee will be served from 09.50 a.m.
The meeting will be held on Wednesday, 8 May 2024 at the offices of the Company at Riverbank House, 2 Swan Lane, London, EC4R 3AD.
There is wheelchair access to the venue. Shareholders with additional accessibility requirements (such as assistive listening solutions) who plan to attend should contact [email protected].
The street-level entrance to Riverbank House is on the corner of Swan Lane and Upper Thames Street. Entry to the building can be gained through the revolving doors.
There are several stations nearby on different lines: Monument and Cannon Street are both served by the District and Circle lines; Bank is served by the Central and Northern lines. Each of these stations are within a tenminute walk of the venue.
Cannon Street (Southeastern) is six minutes' walk away. Fenchurch Street (C2C), Liverpool Street (Greater Anglia, Stansted Express, London Overground, the Elizabeth Line and TfL Rail), Blackfriars (Thameslink) and London Bridge (Southeastern, Southern and Thameslink) are all between ten and twenty minutes' walk away from the venue


Direct Line Insurance Group plc, Registered in England & Wales No. 02280426. Registered Office: Churchill Court, Westmoreland Road, Bromley, BR1 1DP, UK
Notice is hereby given that the Company's AGM will be held at the offices of the Company at Riverbank House, 2 Swan Lane, London, EC4R 3AD at 10.30 a.m. on Wednesday, 8 May 2024, to transact the business set out in the resolutions below.
Resolutions 1 to 19 (inclusive) and 24 will be proposed as ordinary resolutions and resolutions 20 to 23 (inclusive) and 25 will be proposed as special resolutions.
THAT the audited accounts of the Company for the year ended 31 December 2023 together with the Reports of the Directors and of the Auditor be and are hereby received.
THAT the Directors' Remuneration Report set out on pages 131 to 156 of the Annual Report and Accounts be and is hereby approved (excluding the part summarising the Directors' Remuneration Policy which was approved at last years' AGM).
THAT a final dividend of 4.0 pence per ordinary share be and is hereby declared payable on 17 May 2024 to shareholders named on the Register of Members at the close of business on 5 April 2024, provided that the Board may cancel the dividend and therefore payment of the dividend at any time prior to payment, if it considers it necessary to do so for regulatory capital purposes.
THAT David Neave be and is hereby elected as a Director of the Company.
THAT Adam Winslow be and is hereby elected as a Director of the Company.
THAT Carol Hagh be and is hereby elected as a Director of the Company.
THAT Tracy Corrigan be and is hereby re-elected as a Director of the Company.
THAT Danuta Gray be and is hereby re-elected as a Director of the Company.
THAT Mark Gregory be and is hereby re-elected as a Director of the Company.
THAT Adrian Joseph be and is hereby re-elected as a Director of the Company.
THAT Mark Lewis be and is hereby re-elected as a Director of the Company.
THAT Neil Manser be and is hereby re-elected as a Director of the Company.
THAT Fiona McBain be and is hereby re-elected as a Director of the Company.
THAT Gregor Stewart be and is hereby re-elected as a Director of the Company.
THAT Richard Ward be and is hereby re-elected as a Director of the Company.
THAT KPMG LLP be and is hereby appointed as the Company's Auditor until the next AGM.
THAT the Audit Committee of the Board be and is hereby authorised to agree the remuneration of the Auditor.
THAT in accordance with section 366 of the Companies Act 2006 the Company and all companies that are subsidiaries of the Company at any time during the period for which this resolution has effect are authorised to:
provided that the aggregate amount of any such donations and expenditure shall not exceed £100,000, during the period beginning with the date of the passing of this resolution and ending at the conclusion of the next AGM of the Company after the passing of this resolution or, if earlier, at the close of business on 30 June 2025.
For the purpose of this resolution the terms "political donations", "political parties", "independent election candidates", "political organisations" and "political expenditure" have the meanings set out in sections 363 to 365 of the Companies Act 2006.
THAT
i. the Directors be authorised in accordance with article 7 of the Company's articles of association (the "Articles") and section 551 of the Companies Act 2006, to allot shares in the Company, or grant rights to subscribe for or to convert any security into shares in the Company:
a) up to a maximum nominal amount of £47,686,842 (such amount to be reduced by the nominal amount of any equity securities (as defined in article 8 of the Articles) allotted under paragraph b) below in excess of £47,686,842); and
b) comprising equity securities (as defined in article 8 of the Articles) up to a maximum nominal amount of £95,373,684 (such amount to be reduced by the nominal amount of any shares allotted or rights granted under paragraph a) above) in connection with an offer by way of a rights issue (as defined in article 8 of the Articles);
THAT
THAT
in either case as if section 561 of that Act did not apply to the allotment or sale, but this power shall be limited to:
THAT, in accordance with section 701 of the Companies Act 2006, the Company be generally and unconditionally authorised to make market purchases (within the meaning of section 693(4) of the Companies Act 2006) of its ordinary shares on such terms and in such manner as the Directors of the Company may determine, subject to the following conditions:
THAT a general meeting other than an annual general meeting may be called on not less than 14 clear days' notice.
THAT, in addition to the authority granted pursuant to Resolution 19 (authority to allot new shares), the Directors be generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 to exercise all the powers of the Company to allot ordinary shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company:
Unless previously renewed, revoked or varied, the authority conferred by this resolution shall apply in addition to all other authorities under section 551 of the Companies Act 2006 until the conclusion of the next AGM of the Company after the date on which this resolution is passed or, if earlier, the close of business on 30 June 2025, but, in each case, so that the Company may make offers and enter into agreements before the authority expires which would, or might, require shares to be allotted or rights to be granted after the authority expires and the Directors of the Company may allot shares or grant such rights under such an offer or agreement as if the authority conferred hereby had not expired.
THAT, subject to the passing of Resolution 24, the Directors be generally empowered, pursuant to section 570 of the Companies Act 2006, to allot equity securities (as such phrase is defined in section 560(1) of the Companies Act 2006 and is to be interpreted in accordance with section 560(2) of the Companies Act 2006) for cash pursuant to the authority granted by Resolution 24 up to an aggregate nominal amount of £23,250,000 in relation to any issues of RT1 Instruments, free of the restriction in section 561 of the Companies Act 2006.
Unless previously renewed, revoked or varied, the power conferred by this resolution shall apply until the conclusion of the next AGM of the Company after the date on which this resolution is passed or, if earlier, the close of business on 30 June 2025, but, in each case, so that the Company may make offers and enter into agreements before the power expires which would, or might, require equity securities to be allotted after the power expires and the Directors may allot equity securities under such an offer or agreement as if the power conferred hereby had not expired.
This authority is in addition to the authorities conferred by Resolutions 20 (general authority to disapply pre-emption rights) and 21 (additional authority to disapply pre-emption rights).
Reviewed by the Board and signed on its behalf by:
Roger C Clifton Company Secretary
8 April 2024
The Directors must lay before the shareholders the Report and Accounts of the Company for the financial year ended 31 December 2023, which include the Strategic report and the reports of the Directors and of the Auditor.
The Directors' Remuneration Report has been prepared in accordance with the Companies Act 2006 and the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 (as amended). It meets the requirements of the Financial Conduct Authority's Listing Rules and describes how the Board has implemented the Directors' Remuneration Policy and applied the principles of good governance relating to Directors' remuneration. The Directors' Remuneration Report is set out in full on pages 131 to 156 of the Annual Report & Accounts. As required by the Companies Act 2006, an ordinary resolution to approve the Report (excluding the part summarising the Directors' Remuneration Policy which was approved at last years' AGM) is proposed at the AGM. This vote is advisory and the Directors' entitlement to receive remuneration is not conditional upon the resolution being passed by shareholders.
Shareholders may declare the final dividend payable for each ordinary share held and the proposal recommended by the Directors in this resolution is 4.0 pence for each ordinary share. If approved by shareholders, this final dividend for the financial year ended 31 December 2023 will become due and payable on 17 May 2024 to shareholders named on the Register of Members as at the close of business on 5 April 2024, provided that the Board of Directors may cancel the dividend and therefore payment of the dividend at any time prior to payment if it considers it necessary to do so for regulatory capital purposes. In compliance with the rules issued by the Prudential Regulation Authority ("PRA") relating to the implementation of the UK Solvency II regime (as it relates to regulated insurance companies) and other regulatory requirements to which the Group is subject, the dividend is required to remain cancellable at any point prior to it being paid on 17 May 2024, and to be cancelled if, prior to payment, the regulated insurance companies in the Group cease to hold capital resources equal to or in excess of their Solvency Capital Requirement, or if that would be the case if the dividend were paid. The Directors have no intention of exercising this cancellation right, other than where required to do so by the PRA or for regulatory capital purposes.
The Company's Articles of Association require Directors who wish to continue to serve to submit themselves for election or re-election at each AGM.
David Neave was appointed to the Board as a Non-Executive Director with effect from 19 October 2023. Adam Winslow was appointed to the Board as an Executive Director with effect from 21 March 2024. Carol Hagh was appointed to the Board as Non-Executive Director on 1 April 2024. Resolutions will be proposed for their each of their elections at this year's AGM. Jon Greenwood, who was our Acting CEO, stood down from the Board on 21 March 2024.
Tracy Corrigan, Danuta Gray, Mark Gregory, Adrian Joseph, Mark Lewis, Neil Manser, Fiona McBain, Gregor Stewart, and Richard Ward are seeking re-election at this year's AGM. The performance of each Director standing for re-election has been reviewed as part of the Board performance review; it is confirmed that each Director contributes effectively and continues to demonstrate commitment to the role. Through its Nomination and Governance Committee, the Board has undertaken appropriate due diligence on the Directors' other interests and external time commitments and has concluded that the Non-Executive Directors are able to commit fully to their roles and are free from any relationship or circumstances that could affect their judgement and are accordingly considered independent by the Board. The Chair was considered independent on appointment to that role.
Biographical details, in support of each Director's election or re-election, including an explanation of why each Director's contribution is, and continues to be, important to the Company's long-term sustainable success, are provided on pages 11 to 16 below.
Independent Non-Executive Director
October 2023
Audit Committee Board Risk Committee Nomination and Governance Committee
David is a former Chief Executive of General Insurance for Co-operative Insurance. Following his executive career, spanning over twenty years in senior management roles in general insurance, David has held chairmanships, nonexecutive directorships and advisory roles in a number of insurance, InsurTech, consultancy and legal businesses, including Slater and Gordon UK Ltd, The Solicitors Indemnity Fund, Liverpool Victoria Friendly Society and Accenture UK Ltd.
» Chair of the Advisory Board of the Common Automotive Platform Standard.
Chief Executive Officer
March 2024
None
Adam has a deep understanding of the insurance industry and has significant leadership experience. Prior to joining the Group, he was CEO of Aviva UK and Ireland General Insurance, during which time the company saw an increase in overall profitability and market share expansion. Prior to this, Adam served as CEO of International Markets at Aviva. He was previously CEO of Global Life Insurance at AIG International Life and Retirement (now Corebridge). Before that, Adam was CEO for AIG Life UK until 2020, prior to which he held several positions in insurance and life insurance across several markets. Adam's Board experience also includes a role as Non-Executive Director for Pool Reinsurance Company.
None.
Independent Non-Executive Director
April 2024
Nomination and Governance Committee
Carol's career has spanned actuarial services and technology consultancy; brand, marketing and customer strategic development; board and executive search, in which she led Spencer Stuart's UK insurance practice; and senior executive coaching. In senior leadership roles in general insurance, she was responsible for digital transformation, direct channel development, and proposition design. She has led customercentric culture transformation and data-driven approaches to improving customer satisfaction.
» Non-Executive Director and member of the Remuneration and Nominations & Governance Committees of Chesnara PLC.
Independent Non-Executive Director
November 2021
Customer and Sustainability Committee (Chair) Nomination and Governance Committee Remuneration Committee
Tracy's professional background spans financial journalism, digital media and corporate strategy in the media industry. Most recently Tracy was Dow Jones' Chief Strategy Officer where she was responsible for global strategy, customer insight and commercial policy, and had oversight of the digital transformation of the business. Earlier in her career, Tracy was Editor-in-Chief of The Wall Street Journal Europe and Digital Editor of The Wall Street Journal. She also held various positions, including Editor of FT.com and Editor of the Lex Column, at the Financial Times.
Chair of the Board
Independent Non-Executive Director in February 2017. Chair of the Board since August 2020.
Nomination and Governance Committee (Chair) Remuneration Committee
Danuta was Chair of Telefónica in Ireland until 2012. She was Chief Executive between 2001 and 2010, during which time Telefónica's customer base increased to 1.7 million from just under 1 million. Between 1984 and 2001, Danuta held a variety of senior positions within the BT Group. Elsewhere, Danuta has acted as Senior Independent Director of the Aldermore Group; Non-Executive Chair of St Modwen Properties; Non- Executive member of the Ministry of Defence Board, NED and Chair of the Remuneration Committee at both Page Group plc and Old Mutual plc; and was Non-Executive Chair of the Board of Perth Topco Limited and North Tech.
Independent Non-Executive Director
March 2018
Board Risk Committee (Chair) Audit Committee Investment Committee Nomination and Governance Committee Remuneration Committee
Mark was CEO of Merian Global Investors from January 2019 to August 2020. He previously held the role of Group CFO and Executive Director at Legal & General until 2017. Mark acted in a variety of senior roles in his 19-year career at Legal & General, including CEO of the Savings business, Managing Director of the With-Profits business, and Resources and International Director. Earlier in his career, Mark held senior financial and business development roles at ASDA and Kingfisher. Mark is an Associate of the Institute of Chartered Accountants in England & Wales.
» Non-Executive Director and member of the Audit and Risk Committees of Phoenix Group Holdings plc.
Independent Non-Executive Director
January 2021
Customer and Sustainability Committee Nomination and Governance Committee
Adrian is the former Managing Director, Group Data and Artificial Intelligence at BT Group and a former member of HM Government's AI Council. He has significant industry and consultancy experience and has held senior roles at EY and Google. Between 2016 and 2020, Adrian was a NED at the Home Office where he sat on the Data Board advising on data science, digital transformation, and diversity and inclusion. A former Chair of the Race Equality Board, Adrian was appointed to the main Board of Business in the Community in 2014 and continues to act as an adviser to them. In 2018, he was announced as the most influential black, Asian and minority ethnic technology leader in the UK by the Financial Times and Inclusive Boards. Adrian has been awarded an OBE for services to equality and diversity in business.
» None.
Independent Non-Executive Director
March 2023
Customer and Sustainability Committee Nomination and Governance Committee Remuneration Committee
Mark's career has spanned financial services, retail, e-commerce, management consultancy and advertising. Most recently, he was Chief Executive of the MoneySupermarket Group, overseeing a period of revenue and profit growth for the UK listed price comparison business. Mark's previous roles include the Retail and Online Director for John Lewis and the Managing Director of eBay UK.
Chief Financial Officer
May 2021
Investment Committee
Neil has held several roles in Finance and Strategy since joining the Group in 2011, including Director of Investor Relations, Managing Director of NIG and Chief Strategy Officer. He was instrumental in the Group's successful IPO in 2012. He brings extensive industry and capital markets experience to the Board. Prior to joining the Group, Neil held roles at Brit Insurance, Merrill Lynch and Fox-Pitt, Kelton. He is an Associate of the Institute of Chartered Accountants in England and Wales.
» None.
Independent Non-Executive Director
September 2018
Investment Committee (Chair) Audit Committee Board Risk Committee Nomination and Governance Committee
Fiona's experience in retail financial services, both in the industry and as an auditor, was gained in the UK and the USA. Fiona qualified as an accountant early in her career at Arthur Young (now EY). She is a former Chair and Non-Executive Director of the Scottish Investment Trust plc. Until January 2019, she was Vice-Chair of Save the Children UK and a Trustee Director of the Humanitarian Leadership Academy. Previously, Fiona served as CEO of Scottish Friendly Group for 11 years, before which she was Scottish Friendly Group's Finance Director. Between February 2009 and June 2023, she served as Chair and Non-Executive Director of the Scottish Mortgage Investment Trust plc. Fiona is a Fellow of the Institute of Chartered Accountants in England & Wales.
Independent Non-Executive Director
March 2018
Audit Committee (Chair) Board Risk Committee Nomination and Governance Committee
Gregor worked at Ernst & Young for 23 years, 10 of which were as partner in the financial services practice. Between 2009 and 2012, he was Finance Director for the insurance division of Lloyd's Banking Group plc which included Scottish Widows. Gregor previously served as Chair and Non-Executive Director of Alliance Trust plc and FNZ (UK) Limited. Gregor is a Member of the Institute of Chartered Accountants of Scotland.
» Deputy Chair, Chair of the Risk Committee and Non-Executive Director of FNZ Group.
Independent Non-Executive Director
January 2016
Remuneration Committee (Chair) Board Risk Committee Nomination and Governance Committee
Richard was previously Executive Chair of Ardonagh Specialty, Chief Executive of Lloyd's of London, and CEO of the International Petroleum Exchange. He also held the roles of Non-Executive Chair at Brit Syndicates Limited and Executive Chair of Cunningham Lindsey. Richard also held NED roles at the Partnership Assurance Group plc and the London Clearing House. Earlier in his career he held a range of senior positions at British Petroleum and was a research scientist for the Science and Engineering Council. Richard has also been a member of the PwC Advisory Board, the PRA Practitioner Panel and the Geneva Association.
This resolution proposes the appointment of KPMG LLP as the Company's auditor until the next annual general meeting at which the Company's accounts are presented, on the recommendation of the Audit Committee. The recommendation follows a competitive tender process, as described on page 119 of the Annual Report and Accounts 2022. Deloitte LLP, the auditor for the financial year ended 31 December 2023, did not participate in the tender in view of its length of service to the Company. Deloitte LLP has provided a statement of circumstances, as required by company law, which is set out on page 21.
This resolution is separate to resolution 16 and proposes to give authority to the Audit Committee of the Board to determine the Auditor's remuneration.
The Company does not intend to change its current practice of not making donations to political parties. However, the Companies Act 2006 contains restrictions on companies making donations or incurring expenditure in relation to political parties, other political organisations or independent election candidates. Part 14 of the Companies Act 2006 defines political parties, other political organisations and independent election candidates very widely and, as a result, it is possible that they may include, for example, donations to bodies concerned with policy review and law reform, with the representation of the business community or sections of it, or with the representation of other communities or special interest groups which are in the shareholders' interest for the Company to support. Amongst other things, the Companies Act 2006 prohibits the Company or its direct or indirect subsidiaries from making donations or incurring expenditure in relation to political parties, other political organisations or independent election candidates in a 12-month period in excess of an aggregate of £5,000, unless such donations have been authorised by the Company's shareholders. The Company is therefore seeking authority under this resolution to make political donations to political parties, other political organisations or independent election candidates and to incur political expenditure of up to £100,000 in aggregate in order to prevent an inadvertent breach of the Companies Act 2006. As permitted under the Companies Act 2006, this resolution covers the Company and extends to all companies that are subsidiaries of the Company at any time the authority is in place.
At the AGM on 9 May 2023, shareholders approved resolutions to authorise the Directors to allot shares, to allot equity securities for cash, and to make market purchases of the Company's own shares.
This resolution renews the authority that was given at the 2023 AGM to allot shares. Paragraph i) a) of this resolution would give the Directors the authority to allot ordinary shares up to an aggregate nominal amount equal to £47,686,842. This amount represents one-third (33.33%) of the issued ordinary share capital of the Company as Friday, 22 March 2024, the latest practicable date prior to the publication of this Notice.
In line with guidance issued by The Investment Association (the "IA") in February 2023, paragraph i) b) of this resolution would give the Directors the authority to allot ordinary shares in connection with a rights issue or other pre-emptive offer in favour of ordinary shareholders up to an aggregate nominal amount equal to £95,373,684 including, within such limit, the nominal amount of any shares issued under paragraph i) a) of this resolution. This amount represents two-thirds (66.67%) of the issued ordinary share capital of the Company as at Friday, 22 March 2024, the latest practicable date prior to the publication of this Notice.
The authorities sought under this resolution will expire on the earlier of 30 June 2025 (the latest date by which the Company must hold an AGM in 2025) and the conclusion of the AGM of the Company held in 2025.
The Directors have no present intention of exercising either of the authorities sought under this resolution; however, if they do exercise the authority, the Directors intend to follow best practice as regards its use, as recommended by the IA. As at the date of this Notice, no ordinary shares are held by the Company in treasury.
At last year's meeting a special resolution was passed, under sections 570 and 573 of the Companies Act 2006, empowering the Directors to allot equity securities for cash without first being required to offer such shares to existing shareholders in proportion to their existing shareholdings. It is proposed
that this authority be renewed in line with the latest institutional shareholder guidelines, including the revised Statement of Principles published by the Pre-Emption Group in November 2022 (the "2022 Statement of Principles").
If approved, this resolution, which follows the Pre-Emption Group's template resolution, will authorise the Directors, in accordance with the Company's articles of association and the 2022 Statement of Principles, to issue shares in connection with a rights issue or other pre-emptive offer and otherwise to issue shares and/or sell treasury shares for cash without first being required to offer such shares to existing shareholders in proportion to their existing shareholdings:
The total maximum nominal amount of equity securities to which Resolution 20 relates is £17,167,262 (representing approximately 12% of the issued ordinary share capital of the Company as at Friday, 22 March 2024).
The Directors confirm that, should they exercise this authority, they intend to follow best practice as regards its use, including: (i) following the shareholder protections in Part 2B of the 2022 Statement of Principles; and (ii) in respect of any follow-on offer, following the expected features set out in paragraph 3 of Part 2B of the 2022 Statement of Principles.
Resolution 20 will be proposed as a special resolution to grant this authority until the conclusion of the next AGM or, if earlier, the close of business on 30 June 2025 (the latest date by which the Company must hold an AGM in 2025).
Resolution 21 requests further shareholder approval, by way of a separate special resolution in line with the best practice guidance issued by the Pre-Emption Group, for the Directors to allot equity securities and/or sell treasury shares for cash without first being required to offer such securities to existing shareholders in proportion to their existing shareholdings. The proposed resolution, which follows the Pre-Emption Group's template resolution and reflects the 2022 Statement of Principles, will expire on 30 June 2025 or at the conclusion of the AGM in 2025, whichever is the earlier.
The authority granted by this resolution, if passed, will be limited to the allotment of equity securities and the sale of treasury shares for cash:
i. under paragraph. A) of the resolution, up to an aggregate nominal value of £14,306,052 (representing approximately 10% of the issued ordinary share capital of the Company as at Friday, 22 March 2024 (being the latest practicable date prior to publication of this Notice)), to be used only in connection with an acquisition or other capital investment of a kind contemplated by the 2022 Statement of Principles, and which is announced contemporaneously with the allotment, or has taken place in the preceding 12 month
period and is disclosed in the announcement of the allotment; and
ii. under paragraph B) of the resolution, up to an additional aggregate amount equal to 20% of any allotment under paragraph A) of the resolution, for the purposes of making a follow-on offer to existing shareholders as described in the 2022 Statement of Principles. The maximum additional nominal amount that could be issued under paragraph B) of the resolution (based on the authority under paragraph A) being used in full) is £2,861,210 (representing approximately 2% of the issued ordinary share capital of the Company as at Friday, 22 March 2024).
The total maximum nominal amount of equity securities to which Resolution 21 relates is £17,167,262 (representing approximately 12% of the issued ordinary share capital of the Company as at Friday, 22 March 2024).
The Directors confirm that, should they exercise this authority, they intend to follow best practice as regards its use, including: (i) following the shareholder protections in Part 2B of the 2022 Statement of Principles; and (ii) in respect of any follow-on offer, following the expected features set out in paragraph 3 of Part 2B of the 2022 Statement of Principles.
The authority granted by this resolution would be in addition to the general authority to disapply pre-emption rights under resolution 20.
This resolution renews the authority that was given at the 2023 AGM, permitting the Company to buy its own ordinary shares in the market. The maximum number of shares that can be bought under this authority is 131,138,815 which represents 10% of the issued ordinary shares of the Company as at Friday, 22 March 2024, the latest practicable date prior to the publication of this Notice.
The maximum price payable (exclusive of expenses) must not exceed the higher of:
The Directors do not intend to exercise the Company's power to purchase its own shares other than in circumstances where they believe this would result in an increase in earnings per share and be in the best interests of shareholders generally.
The Companies Act 2006 enables companies to hold any of their own shares which they have purchased as treasury shares with a view to possible resale at a future date, rather than cancelling them. The Company holds no ordinary shares in treasury at the date of this Notice. Treasury shares would provide the Company with additional flexibility in the management of its capital base, enabling it either to sell the treasury shares quickly and cost-effectively or to use the treasury shares to satisfy awards under the Company's employee share schemes. If the Directors exercise the authority conferred by this resolution, they may consider holding the shares in treasury, rather than cancelling them.
The total number of options to subscribe for ordinary shares that was outstanding at Friday, 22 March 2024, being the latest practicable date prior to the publication of this Notice, was 25,172,836. The proportion of issued share capital that they represented at that time was 1.91%, and the proportion of issued share capital that they would represent if the full authority to purchase shares (existing and being sought) were used was 2.4%.
The notice period required by the Companies Act 2006 for general meetings of the Company is 21 clear days, unless shareholders approve a shorter notice period which cannot be less than 14 clear days (AGMs must always be held on at least 21 clear days' notice). At the Company's 2023 AGM, shareholders authorised the calling of general meetings, other than an AGM, on not less than 14 clear days' notice, and it is proposed that this authority be renewed. The approval granted by this resolution, if passed, will be effective until the Company's next AGM, when it is intended that a similar resolution will be proposed.
In order to be able to call a general meeting on less than 21 clear days' notice, the Company must make a means of electronic voting available to all shareholders for that meeting. The flexibility offered by this resolution will be used when, taking into account the circumstances, the Directors consider this appropriate in relation to the business to be considered at the meeting and in the interests of the Company and shareholders as a whole.
Resolution 24, will, if approved, renew the authority granted to Directors at the 2023 AGM to allot ordinary shares in the Company or grant rights to subscribe for, or to convert any security into, ordinary shares in the Company, in accordance with section 551 of the Companies Act 2006, up to an aggregate nominal amount of £23,250,000 in connection with the issue of RT1 Instruments which is, in aggregate, equivalent to approximately 16% of the issued ordinary share capital of the Company as at Friday, 22 March 2024, being the latest practicable date prior to the publication of this Notice.
The Directors believe that it is in the best interests of the Company to have the flexibility to issue RT1 Instruments from time to time and the authority sought in resolution 24 may be used if, in the opinion of the Directors, at the relevant time such an issuance of RT1 Instruments would be desirable to improve the capital structure of the Company. However, the request for authority in resolution 24 should not be taken as an indication that the Company will or will not issue any, or any given amount of, RT1 Instruments. This authority is in addition to the authority proposed in resolution 19, which is the usual authority sought on an annual basis in line with the guidance issued by the IA.
This authority will expire at the conclusion of the next AGM of the Company after the date on which this resolution is passed or, if earlier, on 30 June 2025. However, the Directors may seek a similar authority in the future.
Resolution 25, which will be proposed as a special resolution, proposes that, in addition to any authority conferred by resolutions 20 (general authority to disapply pre-emption rights) and 21 (additional authority to disapply pre-emption rights), the Directors be empowered to allot equity securities (as defined in section 560 of the Companies Act 2006) for cash up to a nominal amount of £23,250,000 in relation to the issue of RT1 Instruments, which is equivalent to 16% of the issued ordinary share capital of the Company as at Friday, 22 March 2024 , being the latest practicable date prior to publication of this Notice, as if section 561 of the Companies Act 2006 did not apply to any such allotment.
Resolution 25 would permit the Company the flexibility necessary to allot equity securities pursuant to any proposal to issue RT1 Instruments without the need to comply with the strict pre-emption requirements of the UK statutory regime. Together with resolution 24, resolution 25 is intended to provide the Directors with the continued flexibility to issue RT1 Instruments which may convert into ordinary shares. This will enhance the Company's ability to manage its capital.
This authority will expire at the conclusion of the next AGM of the Company after the date on which this resolution is passed or, if earlier, on 30 June 2025. However, the Directors may seek a similar authority in the future.
Conditional upon the passing of resolutions 24 and 25, the Directors would not expect to make use of the authorities to allot shares and to disapply pre-emption rights granted by resolutions 19 to 21 to issue RT1 Instruments. Any exercise of the authorities in resolutions 19 to 21 (if passed) would be separate from and in addition to the exercise of any powers under resolutions 24 and 25 and would also have a dilutive effect on existing shareholdings.
As noted on page 3 of this document, the Directors made use of the authorities to issue RT1 Instruments that were granted at the 2017 AGM in connection with the Group's issue of such instruments in December 2017. The Directors have not used the authority granted at AGMs between 2018 and 2023.
The shareholder helpline is run by the Registrar, and is available between Monday and Friday, 8.30 a.m. to 5.30 p.m. (excluding public holidays). The helpline also contains automated selfservice functionality which is available 24 hours a day, 7 days a week. Using your Shareholder's Register Number ("SRN") on your proxy form, share certificate or dividend confirmation, the self-service functionality will allow you to:
The number to call is +44 (0)370 873 5880.
Investor Centre is a free and secure share management website provided by the Company's Registrar. Managing your shares online means you can access information quickly and securely, and minimise postal communications. This service will allow you to:
To take advantage of this service, visit Investor Centre at www.investorcentre.co.uk.
The Company actively encourages all shareholders to register for the electronic communications service. You can register for this by visiting www.directlinegroup.co.uk/alerts and following the online instructions.
You can register to give your AGM proxy voting instructions electronically and to access details of your individual shareholding quickly and securely online by visiting www.investorcentre.co.uk and following the online instructions.
The Registrar must receive voting instructions from participants in the Company's share incentive plans by no later than 5.00 p.m. on Tuesday, 30 April 2024, and must receive proxy appointments no later than 10.30 a.m. Friday, 3 May 2024 from ordinary shareholders.
1 New Street Square London EC4A 3HQ Phone: +44 (0)20 7936 3000 Fax: +44 (0)20 7583 0112 www.deloitte.co.uk
Deloitte LLP 1 New Street Square London EC4A 3HQ
Deloitte LLP 1 New Street Square London EC4A 3HQ
Phone: +44 (0)20 7936 3000 Fax: +44 (0)20 7583 0112 www.deloitte.co.uk
Phone: +44 (0)20 7936 3000 Fax: +44 (0)20 7583 0112 www.deloitte.co.uk
25 March 2024 BR1 1DP
Bromley
25 March 2024
Bromley BR1 1DP
Westmoreland Road
25 March 2024
Churchill Court Westmoreland Road
Direct Line Insurance Group plc
Churchill Court
Westmoreland Road Ceasing to act as auditors of Direct Line Insurance Group plc
Bromley This letter is formal notice that we will not be seeking reappointment as auditors of Direct Line Insurance
BR1 1DP
Dear Directors Group plc with effect from the conclusion of the forthcoming accounts meeting.
This letter is formal notice that we will not be seeking reappointment as auditors of Direct Line Insurance Group plc with effect from the conclusion of the forthcoming accounts meeting. Dear Directors attention of members and creditors, is attached.
Our statement of reasons, together with circumstances which we believe should be brought to the attention of members and creditors, is attached. Ceasing to act as auditors of Direct Line Insurance Group plc
Yours faithfully This letter is formal notice that we will not be seeking reappointment as auditors of Direct Line Insurance Yours faithfully
Group plc with effect from the conclusion of the forthcoming accounts meeting. Our statement of reasons, together with circumstances which we believe should be brought to the
Deloitte LLP attention of members and creditors, is attached.
We are not seeking reappointment as auditors of the company and, accordingly, will cease. The reason for our not seeking reappointment is that we have reached our maximum tenure under s494ZA Companies Act 2006 and therefore can no longer act as auditor.
Unless you apply to the Court, this statement must be sent by you within 14 days to every person entitled under Section 423 of the Companies Act 2006 to be sent copies of the company's accounts. This is a requirement of Section 520(2) of that Act. Unless you inform us that you have applied to the court, we are required to file a copy of this statement at Companies House.
www.deloitte.com/about to learn more about our global network of member firms.
www.deloitte.com/about to learn more about our global network of member firms.
© 2024 Deloitte LLP. All rights reserved.
London, EC4A 3HQ, United Kingdom.
© 2024 Deloitte LLP. All rights reserved.
Under s523 Companies Act 2006 you are obliged to inform the FRC, as the appropriate audit authority, of the reasons for our ceasing to hold office. You can do this by email to [email protected] or in writing to Change of Auditor Notifications, Financial Reporting Council, 8th Floor, 125 London Wall, London, EC2Y 5AS. You should either (a) attach a copy of our statement of reasons, saying that you agree with the contents of the statement, or (b) set out what you believe the reasons are for our ceasing to hold office, including your company's registered name and number, our name and address (Deloitte LLP, 1 New Street SquareEC4A 3HQ) and our audit registration number which is C009201919.
Deloitte LLP is a limited liability partnership registered in England and Wales with registered number OC303675 and its registered office at 1 New Street Square, London, EC4A 3HQ, United Kingdom.
Deloitte LLP is the United Kingdom affiliate of Deloitte NSE LLP, a member firm of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"). DTTL and each of its member firms are legally separate and independent entities. DTTL and Deloitte NSE LLP do not provide services to clients. Please see www.deloitte.com/about to learn more about our global network of member firms. © 2024 Deloitte LLP. All rights reserved. Deloitte LLP is a limited liability partnership registered in England and Wales with registered number OC303675 and its registered office at 1 New Street Square, London, EC4A 3HQ, United Kingdom. Deloitte LLP is the United Kingdom affiliate of Deloitte NSE LLP, a member firm of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee
("DTTL"). DTTL and each of its member firms are legally separate and independent entities. DTTL and Deloitte NSE LLP do not provide services to clients. Please see
Deloitte LLP is a limited liability partnership registered in England and Wales with registered number OC303675 and its registered office at 1 New Street Square,
Deloitte LLP is the United Kingdom affiliate of Deloitte NSE LLP, a member firm of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"). DTTL and each of its member firms are legally separate and independent entities. DTTL and Deloitte NSE LLP do not provide services to clients. Please see
| and the control control control control control control controller and the consideration of the consideration of the consideration of the consideration of the consideration o | |
|---|---|
| and the control control control control control controller and the controllers and the controllers and the controllation of the controllers of the controlled to the controlle | |
| and the same of the same of the same of the same of the same of the same of the same of the states of the states of the states of the states of the states of the states of th | |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | |
| and the same of the same of the same of the same of the same of the same of the same of the same of the same of the same of the same of the subsequence and | |
| and the control control control control control controllation and consideration of the consideration of the consideration of the consideration of the consideration of the con | |
| Direct Line Group Notice of Meeting 2024 | 23 |
|---|---|
| ------------------------------------------ | ---- |

Direct Line Insurance Group plc© Registered in England & Wales No 02280426. Registered Office: Churchill Court, Westmoreland Road, Bromley, BR11DP
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.